Finland – Pharmaceutical products – Nirmatrelviirin ja ritonaviirin yhdistelmävalmisteen (PAXLOVID tabletti, kalvopäälly
HUS-Yhtymä awarded €8.0M to Pfizer Oy for Healthcare & Medical in February 2024 — one of 1,479 awards this buyer has made, above its typical award size.
Buying agency
HUS-YhtymäWinning supplier
Pfizer OyContract description
Finland – Pharmaceutical products – Nirmatrelviirin ja ritonaviirin yhdistelmävalmisteen (PAXLOVID tabletti, kalvopäällysteinen 150 mg + 100 mg) suorahankinta
Related awards · HUS-Yhtymä
1,479 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-500745-2024Renalis Oü€40.0M21 Aug 2024 Healthcare
- ocds-ted-206235-2024Gasum Oy€35.0M08 Apr 2024 Energy
- ocds-ted-432352-2026DHL Supply Chain (Finland) Oy€25.4M25 Jun 2026 Professional Services
Other wins · Pfizer Oy
4 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-179908-2025Sosiaali- ja terveysministeriö€3.2M20 Mar 2025 Professional Services
- ocds-ted-275726-2026-2Sansia OyNot disclosed22 Apr 2026 Healthcare
- ocds-ted-655928-2024-2Terveyden ja hyvinvoinnin laitosNot disclosed29 Oct 2024 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for HUS-Yhtymä and Pfizer Oy — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back